183 related articles for article (PubMed ID: 14675328)
1. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases.
Xue WC; Feng HC; Tsao SW; Chan KY; Ngan HY; Chiu PM; Maccalman CD; Cheung AN
Int J Gynecol Cancer; 2003; 13(6):879-88. PubMed ID: 14675328
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma.
Xue WC; Chan KY; Feng HC; Chiu PM; Ngan HY; Tsao SW; Cheung AN
J Mol Diagn; 2004 Nov; 6(4):326-34. PubMed ID: 15507671
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.
Wong SY; Ngan HY; Chan CC; Cheung AN
Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
Mod Pathol; 2011 Apr; 24(4):522-32. PubMed ID: 21102414
[TBL] [Abstract][Full Text] [Related]
5. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
[TBL] [Abstract][Full Text] [Related]
6. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.
Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ
Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982
[TBL] [Abstract][Full Text] [Related]
7. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of PDCD4 by deSUMOylation associates with the progression of gestational trophoblastic disease.
Wang YX; Cui L; Wu WB; Quinn MJ; Menon R; Zhao JR; Zhang HJ
Placenta; 2022 Dec; 130():17-24. PubMed ID: 36370491
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.
Siu MK; Wong ES; Chan HY; Ngan HY; Chan KY; Cheung AN
Am J Pathol; 2008 Oct; 173(4):1165-72. PubMed ID: 18772339
[TBL] [Abstract][Full Text] [Related]
11. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the Parkinson disease protein DJ-1 and its regulator PTEN in gestational trophoblastic disease.
Zhang HJ; Siu MK; Jiang LL; Mak VC; Ngan HY; Cheung AN
Int J Gynecol Pathol; 2010 Sep; 29(5):468-75. PubMed ID: 20736773
[TBL] [Abstract][Full Text] [Related]
13. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases.
Fulop V; Colitti CV; Genest D; Berkowitz RS; Yiu GK; Ng SW; Szepesi J; Mok SC
Oncogene; 1998 Jul; 17(4):419-24. PubMed ID: 9696034
[TBL] [Abstract][Full Text] [Related]
14. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms.
Lei ZM; Rao CV; Ackerman DM; Day TG
J Clin Endocrinol Metab; 1992 Jun; 74(6):1236-41. PubMed ID: 1592864
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts.
Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH
Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration.
Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W
Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393
[TBL] [Abstract][Full Text] [Related]
17. Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study.
Fong PY; Xue WC; Ngan HY; Chan KY; Khoo US; Tsao SW; Chiu PM; Man LS; Cheung AN
Cancer; 2005 Jan; 103(2):268-76. PubMed ID: 15578716
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
19. Caspase activity is downregulated in choriocarcinoma: a cDNA array differential expression study.
Fong PY; Xue WC; Ngan HY; Chiu PM; Chan KY; Tsao SW; Cheung AN
J Clin Pathol; 2006 Feb; 59(2):179-83. PubMed ID: 16443735
[TBL] [Abstract][Full Text] [Related]
20. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]